Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Roberta Baltera, Stuart Collinson, Robert Millman

Premium

Arcturus Therapeutics has appointed Robert Baltera and Stuart Collinson to its board of directors.

Baltera previously served as CEO of Amira Pharmaceuticals, which was acquired by Bristol-Myers Squibb. Before that, he held various roles at Amgen. He is currently on the board of Organovo Holdings, Xencor, Panmira Pharmaceuticals, and San Diego Venture Group.

Collinson is a partner at investment firm Forward Ventures and is executive chairman of Tioga Pharmaceuticals. He previously was chairman, CEO, and president of Aurora Biosciences, which was acquired by Vertex. He has also held different senior management positions at GlaxoWellcome (now GlaxoSmithKline) and Baxter International.


Tauriga Sciences has appointed Robert Millman to its business advisory board.

Millman is currently a managing director at MPM Capital and previously was chief intellectual property counsel for Alnylam Pharmaceuticals.

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.